Crossmark

Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study

Crossref DOI link: https://doi.org/10.1186/s12893-023-02087-3

Published Online: 2023-07-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Dao-Ning

Jia, Wei-Wei

Wang, Hai-Yue

Wu, Jian-Hui

Li, Cheng-Peng

Hao, Chun-Yi http://orcid.org/0000-0002-1233-1689
License Information

Text and Data Mining valid from 2023-07-04

Version of Record valid from 2023-07-04
More Information

Article History

Received: 31 January 2023

Accepted: 21 June 2023

First Online: 4 July 2023

Declarations

:

: Ethical approval was obtained from Beijing Cancer Hospital Medical Ethics Committee. Written informed consent were obtained from all participants. All experiments were performed in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below